13F Filings History of Inspire Advisors, LLC

Latest 13F report
Q4 2025 - 13 Feb 2026
Value $
$1,086,739,337
Signature - Title
Aaron Moon - Chief Compliance Officer/Investment Adviser Representative
Location
Meridian, ID
Summary
This page shows a list of all the recent 13F filings made by Inspire Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Inspire Advisors, LLC reported 547 stock holdings with total value $1,086,739,337 as of Q4 2025. Top holdings included WWJD, IBD, RISN, PTL, and ISMD.

Notify me when Inspire Advisors, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 547 $1,086,739,337 +$153,738,625 -$119,350,938 +$34,387,687 WWJD, IBD, RISN, PTL, ISMD 13F-HR 13 Feb 2026, 16:46
Q3 2025 528 $1,045,181,451 +$107,806,914 -$77,761,854 +$30,045,060 WWJD, RISN, IBD, ISMD, PTL 13F-HR 29 Oct 2025, 12:33
Q2 2025 497 $963,834,650 +$193,784,557 -$138,075,849 +$55,708,708 WWJD, RISN, IBD, ISMD, PTL 13F-HR 11 Aug 2025, 15:32
Q1 2025 449 $865,252,466 +$161,801,858 -$104,206,963 +$57,594,895 WWJD, IBD, RISN, ISMD, PTL 13F-HR 07 May 2025, 12:46
Q4 2024 414 $817,435,634 +$81,143,417 -$66,583,933 +$14,559,484 WWJD, RISN, IBD, ISMD, PTL 13F-HR 07 Feb 2025, 16:42
Q3 2024 423 $822,442,408 +$115,064,368 -$90,422,759 +$24,641,609 WWJD, RISN, IBD, ISMD, PTL 13F-HR 17 Oct 2024, 16:25
Q2 2024 376 $754,201,110 +$208,331,496 -$164,506,949 +$43,824,547 IBD, WWJD, RISN, USFR, ISMD 13F-HR 08 Aug 2024, 16:23
Q1 2024 373 $722,577,093 +$101,592,002 -$70,868,949 +$30,723,053 RISN, IBD, WWJD, BIBL, BLES 13F-HR 07 May 2024, 16:50
Q4 2023 336 $665,464,380 +$141,723,823 -$89,259,387 +$52,464,436 RISN, IBD, WWJD, ISMD, BLES 13F-HR 12 Feb 2024, 14:46
Q3 2023 279 $566,375,975 +$102,765,639 -$36,716,900 +$66,048,739 IBD, RISN, WWJD, USFR, BLES 13F-HR 26 Oct 2023, 11:48
Q2 2023 244 $518,175,817 +$98,277,562 -$27,830,833 +$70,446,729 RISN, IBD, WWJD, BLES, USFR 13F-HR 31 Jul 2023, 10:20
Q1 2023 203 $436,199,837 +$85,746,066 -$53,133,488 +$32,612,578 RISN, IBD, WWJD, USFR, BLES 13F-HR 24 Apr 2023, 10:24
Q4 2022 185 $396,229,723 +$47,164,973 -$32,026,059 +$15,138,914 RISN, IBD, WWJD, BLES, BIBL 13F-HR 26 Jan 2023, 14:28
Q3 2022 156 $364,205,000 +$69,493,740 -$49,876,924 +$19,616,816 RISN, IBD, BLES, WWJD, BIBL 13F-HR 07 Nov 2022, 16:56
Q2 2022 117 $357,492,000 +$90,759,232 -$58,759,474 +$31,999,758 RISN, IBD, USFR, WWJD, BLES 13F-HR 10 Aug 2022, 09:11
Q1 2022 112 $356,224,000 +$77,544,621 -$52,018,036 +$25,526,585 RISN, IBD, VGSH, BLES, WWJD 13F-HR 21 Apr 2022, 10:04
Q4 2021 99 $353,187,000 +$54,270,815 -$13,458,245 +$40,812,570 RISN, IBD, ISMD, BLES, WWJD 13F-HR 02 Feb 2022, 17:32
Q3 2021 91 $317,324,000 +$27,070,537 -$11,806,021 +$15,264,516 RISN, IBD, ISMD, WWJD, BLES 13F-HR 09 Nov 2021, 13:56
Q2 2021 88 $307,151,000 +$30,849,445 -$16,790,494 +$14,058,951 RISN, ISMD, IBD, WWJD, BLES 13F-HR 10 Aug 2021, 16:53
Q1 2021 77 $276,763,000 +$22,425,543 -$29,306,341 -$6,880,798 RISN, ISMD, IBD, WWJD, BLES 13F-HR 30 Apr 2021, 12:23
Q4 2020 781 $267,852,000 $0 $0 $0 RISN, ISMD, IBD, WWJD, BLES 13F-HR 12 Feb 2021, 14:47